Research & Development

Follow topic
30 Apr 2021
Insilico Advisor improves the efficiency of biologics manufacturing

Insilico Biotechnology AG has released a new product, the Insilico Advisor to improve efficiency of biologics manufacturing. The manufacturing of…

Insilico Advisor improves the efficiency of biologics manufacturing

Insilico Biotechnology AG has released a new product, the Insilico Advisor to improve efficiency of biologics manufacturing. The manufacturing of biologics with consistent quality is challenging. Since the quality of biologics is impacted greatly by the cell culture process, the robustness of this process must be maintained in the face…

23 Feb 2021
Cable, components and critical space exploration

As NASA’s Mars Perseverance rover begins exploring its new planetary home after landing on 18 February 2021. Operating with the…

Cable, components and critical space exploration

As NASA’s Mars Perseverance rover begins exploring its new planetary home after landing on 18 February 2021. Operating with the world’s most advanced technology. Equipped with Ty-Rap™ cable ties from ABB. The same ties used on earth. Designed for extreme environments Found in buildings; subways; the deepest oceans and outer…

18 Nov 2020
R&D collaboration advances treatment of immune mediated diseases

Lead Pharma, a clinical stage pharmaceutical company that designs and develops medicines for the treatment of immune mediated diseases and…

R&D collaboration advances treatment of immune mediated diseases

Lead Pharma, a clinical stage pharmaceutical company that designs and develops medicines for the treatment of immune mediated diseases and cancer, has entered into a collaboration and licence agreement with Roche to develop oral small molecules to treat a broad range of immune mediated diseases. In this single target research…

05 Nov 2020
L’Oréal R&I wins applied research award at the IFSCC Congress 2020

At the 31st International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2020 Yokohama, which took place virtually from 21 to…

L’Oréal R&I wins applied research award at the IFSCC Congress 2020

At the 31st International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2020 Yokohama, which took place virtually from 21 to 30 October, L’Oréal R&I unveiled its latest advances in skin and hair research.  Among the 441 projects selected by the Japanese jury, L’Oréal R&I researchers filled half of the programme…

13 Oct 2020
Online concrete training programme for 2021

The Concrete Institute’s School of Concrete Technology (SCT) has finalised its programme of online training courses for 2021. Fourteen courses…

Online concrete training programme for 2021

The Concrete Institute’s School of Concrete Technology (SCT) has finalised its programme of online training courses for 2021. Fourteen courses are in the plan. It includes the start of the pinnacle of concrete diploma courses: Advanced Concrete Technology. John Roxburgh, the senior lecturer at the SCT, says the SCT ran…

23 Sep 2020
Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility…

Merck expands its ADC manufacturing capabilities

Merck has announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Completion is expected by mid-2022 and should…

27 Aug 2020
Intravacc’s candidate RSV vaccine demonstrates safety in phase I trial

Intravacc has announced, in the medical journal Vaccine, a clinical phase I study with its candidate Respiratory Syncytial Virus (RSV)…

Intravacc’s candidate RSV vaccine demonstrates safety in phase I trial

Intravacc has announced, in the medical journal Vaccine, a clinical phase I study with its candidate Respiratory Syncytial Virus (RSV) vaccine. The vaccine showed excellent induction of immunogenicity after nasal administration to healthy adult volunteers (18-50 years). In addition, the Live Attenuated Vaccine (LAV), constructed with reverse genetics, appears to…

14 Nov 2019
Calling on the next generation of SA medical researchers for the NGS Program

The Novartis and the University of Basel Next Generation Scientist (NGS) Program is now preparing to receive its 2020 intake…

Calling on the next generation of SA medical researchers for the NGS Program

The Novartis and the University of Basel Next Generation Scientist (NGS) Program is now preparing to receive its 2020 intake of researchers. The program is aimed at driving the scientific and professional development of talented young research scientists from different countries across Africa, Latin America and Asia. Since its inception…

11 Nov 2019
The next generation in biotech and cell and gene manufacturing

Werum is launching a new version of its market-leading PAS-X Manufacturing Execution System (MES): PAS-X 3.2. It will be globally…

The next generation in biotech and cell and gene manufacturing

Werum is launching a new version of its market-leading PAS-X Manufacturing Execution System (MES): PAS-X 3.2. It will be globally available in January 2020 and can be ordered from today. It covers, in particular, biopharmaceutical and cell and gene therapy manufacturing as these fast-growing industries rely heavily on efficient digital…

06 Nov 2019
How to speed up your 384 well pipetting

If you need to speed up your 384 well pipetting look no further than Integra Biosciences. The company is dedicated…

How to speed up your 384 well pipetting

If you need to speed up your 384 well pipetting look no further than Integra Biosciences. The company is dedicated to developing innovative solutions to everyday pipetting challenges, and offers an array of options to simplify and enhance 384 well pipetting, from multichannel manual pipettes to pipetting robots Reduce the…

29 Oct 2019
EIB loan will finance Mabion’s R&D into treatment for blood cancer

The European Investment Bank (EIB) will lend Polish biotech company, Mabion EUR 30 million to finance its growth plans. Mabion…

EIB loan will finance Mabion’s R&D into treatment for blood cancer

The European Investment Bank (EIB) will lend Polish biotech company, Mabion EUR 30 million to finance its growth plans. Mabion will use the financing for a wide-ranging research and development programme, conducting clinical trials, as well as expending its manufacturing capacities with state-of-the-art equipment. The company expects to employ 96…

19 Aug 2019
Get the most out of supplements with fulvisomes

Lack of absorption has long been a valid criticism against the supplement industry with many doctors saying vitamins do nothing…

Get the most out of supplements with fulvisomes

Lack of absorption has long been a valid criticism against the supplement industry with many doctors saying vitamins do nothing but create expensive urine. Liposomal technology has since entered the arena, however, and caused a quiet revolution with its promise of superior absorption. Liposomal technology has been used in the…


Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za